Literature DB >> 15606392

The usual medical care for irritable bowel syndrome.

W E Whitehead1, R L Levy, M Von Korff, A D Feld, O S Palsson, M Turner, D A Drossman.   

Abstract

AIMS: To determine what constitutes usual medical care for irritable bowel syndrome, which patient characteristics influence choice of treatment and how satisfied patients are with care.
METHODS: Patient encounters in a health maintenance organization were prospectively monitored to identify visits coded irritable bowel syndrome, abdominal pain, constipation or diarrhoea. Within 2 weeks these patients were sent postal questionnaires (n = 1770, 59% participation) to assess patient characteristics and treatment recommendations. Responders were sent follow-up questionnaires 6 months later (77% participation) to assess adherence and satisfaction with treatment.
RESULTS: Treatments employed most frequently were dietary advice, explanation, exercise advice, reassurance, advice to reduce stress and antispasmodic medications. Primary care physicians and gastroenterologists provided similar treatments. Patient confidence was higher for lifestyle advice (63-67, 100-point scale) than for medications (46-59). However, adherence was greater for medications (62-79 vs. 59-69, 100-point scale). Satisfactory relief was reported by 57%, but only 22% reported that symptom severity was reduced by half. Usual medical treatment was less effective for irritable bowel syndrome than for constipation, diarrhoea, or abdominal pain.
CONCLUSIONS: Usual medical care for irritable bowel syndrome emphasizes education and lifestyle modification more than drugs; patients have a greater expectation of benefit from lifestyle modification than drugs. Overall 57% of irritable bowel syndrome patients report satisfactory relief.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606392     DOI: 10.1111/j.1365-2036.2004.02256.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

1.  IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.

Authors:  Olafur S Palsson; Jeffrey S Baggish; Marsha J Turner; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2011-11-08       Impact factor: 10.864

Review 2.  Use of psychopharmacological agents for functional gastrointestinal disorders.

Authors:  R E Clouse; P J Lustman
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 3.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

4.  A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

Authors:  Edith Lahner; Stefano Bellentani; Rudy De Bastiani; Cesare Tosetti; Michele Cicala; Gianluca Esposito; Paolo Arullani; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

5.  Effect of self-management intervention on cortisol and daily stress levels in irritable bowel syndrome.

Authors:  Wimon Deechakawan; Kevin C Cain; Monica E Jarrett; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2011-07-15       Impact factor: 2.522

6.  Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits.

Authors:  Motoyori Kanazawa; Olafur S Palsson; Syed I M Thiwan; Marsha J Turner; Miranda A L van Tilburg; Lisa M Gangarosa; Denesh K Chitkara; Shin Fukudo; Douglas A Drossman; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

Review 7.  Complementary and alternative medicine for treatment of irritable bowel syndrome.

Authors:  Yi-Hao A Shen; Richard Nahas
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

8.  Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist.

Authors:  Olafur S Palsson; William E Whitehead
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-24       Impact factor: 11.382

Review 9.  Managing irritable bowel syndrome.

Authors:  Joyce K Anastasi; Bernadette Capili; Michelle Chang
Journal:  Am J Nurs       Date:  2013-07       Impact factor: 2.220

10.  Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.

Authors:  Susan A Gaylord; William E Whitehead; Rebecca S Coble; Keturah R Faurot; Olafur S Palsson; Eric L Garland; William Frey; John Douglas Mann
Journal:  BMC Complement Altern Med       Date:  2009-07-28       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.